Because many endogenous molecules, hormones and cytokines are deemed to regulate hepatic CYP2E1 expression and activity, sometimes with opposite effects [10,82,135–137], it is possible that CYP2E1 induction might not always occur in obesity and NAFLD. Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.